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Abstract  The  analysis  of  myocardial  perfusion  is  a  key  step  in  the  cardiac  MRI  examination.
In routine  work,  this  exploration  carried  out  at  rest  is  based  on  the  qualitative  ﬁrst  pass  study
of gadolinium  with  an  ECG-triggered  saturation  recovery  bFFE  sequence.  In  view  of  recent
knowledge,  the  analysis  of  the  myocardial  perfusion  under  vasodilator  stress  may  be  carried
out by  scintigraphy  or  MRI,  the  latter  beneﬁting  from  the  absence  of  exposure  to  ionizing  rays
and a  lower  cost.  Besides  coronary  disease,  the  perfusion  sequence  provides  a  rich  semiology
to compare  with  the  clinics  and  the  data  from  other  sequences.  Arterial  Spin  Labeling  (ASL)  is
an alternative  technique  used  in  the  animal  to  quantify  myocardial  perfusion.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
In  human  clinical  practice,  myocardial  perfusion  is  mainly  studied  in  imaging  by  scintigra-
phy  or  MRI.  We  will  concentrate  on  MRI,  even  if  the  isotopic  examinations  are  still  most
common  in  cardiology  in  France  and  throughout  the  world.
The  ﬁrst  pass  perfusion  sequence  acquired  in  real  time  during  the  injection  of  gadolin-
ium  is  an  integral  part  of  the  conventional  cardiac  MRI  protocol.
It  is  also  the  key  MRI  sequence  under  vasodilator  stress  in  the  diagnosis  of  myocardial
ischemia.  The  interpretation  is  usually  qualitative  (visual).
It  should  not  be  confused  with  the  late  enhancement  sequence,  carried  out  10  to
20  minutes  after  the  injection  of  contrast  product,  that  aims  at  identifying  the  pathological
myocardium  retaining  the  gadolinium  (necrosis,  ﬁbrosis,  inﬂammation).
∗ Corresponding author. Radiodiagnostic et Imagerie Médicale (Imagerie Cardiaque Non Invasive), CHU Charles-Nicolle, 1, rue de Germont,
76031 Rouen cedex, France.
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In  all  cases,  the  analysis  of  myocardial  perfusion  is
ntegrated  with  the  data  from  other  sequences.  This
omprehensive  analysis  (CINE,  edema,  perfusion,  late
nhancement  sequences),  without  blind  zone,  is  the  great
dvantage  of  MRI  over  other  techniques.
In  this  article,  we  will  discuss  the  principles  for  perfusion
nalysis,  then  illustrate  the  main  applications,  before  con-
luding  with  the  alternative  techniques  used  in  the  small
nimal.
echnique
est perfusion
his  basic  sequence  in  the  conventional  examination
nvolves  a  multi-slice  acquisition  with  saturation  recovery
SR),  most  often  in  balanced  fast  ﬁeld  echo  gradient  (bFFE)
1].  It  consists  of  a  high  temporal  resolution  sequence,  that
roduces  a  signal  highly  dependent  on  the  relaxation  time
1,  and  its  shortening  induced  by  gadolinium  for  which  the
avity  and  myocardial  transit  is  monitored  in  real  time.
The  operator  plans  a  number  of  slices  that  depends  on
he  R-R  space  of  the  ECG.  This  number  will  be  increased
n  patients  with  low  cardiac  frequency.  With  current  1.5T
achines  and  a  patient  with  around  machines  60—70  beats
er  minute,  it  is  possible  to  place  four  to  ﬁve  slice  planes
n  an  R-R  space  (typically,  two  to  three  slices  in  the  short
xis,  one  slice  in  the  4-chamber  view,  and  a  last  one  along
he  LV  axis).  The  slices  are  deﬁned  according  to  the  disorder
uspected.
In  certain  cases,  it  is  possible  to  place  ﬁve  slices  in  a sin-
le  plane  (the  search  for  a  shunt  may,  for  example,  beneﬁt
rom  a  stack  of  joint  slices  in  the  4-chamber  view).
The  injection  protocol  may  vary  according  to  the
atient’s  habits  and  the  disorder  suspected.  In  our  centre,
e  routinely  inject  a  full  dose  of  gadolinium  chelate  at  5  cc/s
0.1  mmole/kg  or  0.2  mL/kg  if  it  consists  of  a  semi-molar
roduct  or  0.1  mL/kg  if  it  consists  of  a  molar  product).  In  all
ases,  the  gadolinium  is  pulsed  by  saline  solution  (30  cc  in
he  adult).
It  is  possible  to  stick  to  this  dose  to  obtain  a  late  enhance-
ent  of  quality.
However,  certain  teams  recommend  the  use  of  a  ‘‘double
ose’’  of  gadolinium  to  optimize  the  sequences  of  late
nhancement,  and  re-inject  the  same  quantity  of  contrast
roduct  after  the  acquisition  of  the  ﬁrst  pass  perfusion
equence.
The  sequence  can  be  carried  out  with  free  breathing.  An
pnea  may  be  solicited  (without  stress,  the  patient  is  simply
sked  to  stop  breathing  for  about  20  s)  when  the  gadolin-
um  appears  in  the  superior  vena  cava,  especially  if  one
ants  to  quantify  the  perfusion  phenomenon  with  an  input
unction.
The  right  cavities,  the  arterial  vessels,  the  pulmonary
eins,  and  then  the  left  cavities  become  opaque  in  this  order
Fig.  1).  Finally,  the  myocardium  is  enhanced  according  to
n  often-visible  epi-endocardial  gradient,  in  particular  in
ase  of  hypertrophy  of  the  myocardium.  Following  an  apnea
f  about  20  s,  the  patient  may  gently  start  breathing  again
efore  the  end  of  the  sequence  that  lasts  for  a  total  of  about
0  s.
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erfusion under vasodilator stress
he  principle  is  to  reveal  any  perfusion  asymmetry
etween  different  coronary  distribution  territories  of  the
yocardium.  A  vasodilator  (adenosine  or  dipyridamole)  is
dministered  to  a  patient  well  informed  of  the  adverse
ffects  (ﬂush,  headaches)  and  closely  monitored  (visual
urveillance,  ECG,  arterial  pressure,  PaO2)  after  checking
or  the  absence  of  any  contraindication  [2].  The  drug  acts
n  the  healthy  arterial  trunks,  provided  that  the  patient
as  not  taken  or  received  one  of  its  inhibitors,  in  partic-
lar  coffee  (the  consumption  of  coffee  in  the  morning  is  the
ain  practical  restriction  for  this  examination).  The  dila-
ion  of  the  healthy  vessels  induces  a vascular  steal  syndrome
o  the  detriment  of  the  ischemic  territories.  The  ﬁrst  pass
erfusion  sequence  carried  out  in  the  conditions  described
bove  reveals  a  hypoperfusion  (relative  hyposignal)  of  the
schemic  territories  (Fig.  2).
The  detection  of  such  an  anomaly  suggests  the  indication
f  revascularization  and  also  guides  the  procedure  towards
he  ischemic  territory  after  comparison  with  the  imaging  of
he  coronary  network.
Technically,  several  variants  are  possible.  The  above  pro-
ocol  is  applied.  It  is  simply  necessary  to  adapt  the  number
f  slices  acquired  to  the  heart  rate  that  will  increase  with
he  injection  of  the  vasodilator.
Stress  perfusion  should  always  come  before  rest  per-
usion,  since  the  diagnosis  of  ischemia  (relative  hyposignal)
s  easier  at  the  ﬁrst  pass  of  gadolinium.  In  most  teams,
he  stress  perfusion  is  completed  with  a rest  perfusion.  The
urpose  of  this  double  injection  (2  ×  0.05  mmol/kg  of  semi-
olar  contrast)  is  to  make  sure  of  the  absence  of  artifact
hyposignal  in  bands  in  the  septum  that  does  not  change
rom  one  sequence  to  the  next)  by  slice-by-slice  comparison
f  the  two  sequences.
The  interpretation  of  the  examination  is  always  con-
ronted  with  the  analysis  of  the  global  and  segmental
inetics  as  well  as  a  late  enhancement.
There  is  increased  certainty  that  the  vasodilatation  has
topped  (return  to  a  state  of  rest)  when  adenosine  is  used,
hose  tolerance  is  excellent  and  whose  half-life  is  very
hort,  than  with  dipyridamole  whose  half-life  is  longer
nd  whose  effect  has  to  be  cancelled  by  the  injection  of
heophylline.  The  disadvantage  of  adenosine  is  due  to  the
rice,  much  higher  than  that  of  dipyridamole.  Regadeno-
on  is  now  proposed  in  this  indication.  We  have  not  yet
sed  it.
Other  authors  consider  that  if  the  stress  perfusion  is  nor-
al,  it  is  not  useful  to  re-inject  the  patient  to  obtain  a  rest
cquisition.
There  are  at  least  two  alternatives  to  vasodilators  in  MRI:
the  physical  exertion  stress  test  (when  the  patient  is  able
to  undergo  it)  is  the  most  effective  and  physiological  way
to  assess  the  coronary  reserve.  However,  the  stress  is  not
easy  to  implement  in  an  MRI  environment  and  this  test  is
not  carried  out  on  a  routine  basis.  When  the  patient  is  able
to  undergo  a  signiﬁcant  stress,  he  is  now  more  willingly
directed  towards  nuclear  medicine,  where  the  post-stress
measurement  will  be  compared  with  the  measurement  at
rest;
certain  teams  use  ‘‘high  dose’’  dobutamine.  It  constitutes
a  purer  ischemic  stress  than  the  vasodilator,  by  increasing
Is  it  possible  to  do  without  the  study  of  myocardial  perfusion  in  2013?  1339
cted
avitieFigure 1. Slices in the 4-chamber view (horizontal long axis) extra
the kinetics of the contrast product. a: opaciﬁcation of the right c
enhancement.the  myocardial  work.  In  this  case,  the  ﬁrst  pass  perfusion
is  not  studied  but  the  global  contractility  (evolution  of  the
ejection  fraction)  and  segmental  contractility  (appear-
ance  of  a  segmental  kinetic  disorder  in  case  of  ischemia).
Figure 2. Slice in the short axis of the heart extracted from a per-
fusion sequence under vasodilator stress. Anterior septal ischemia.
The anterior territory (anterior interventricular artery) presents a
distinct hyposignal under stress, attesting to a detrimental per-
fusion asymmetry.
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i from a ﬁrst pass perfusion sequence. Normal examination showing
s; b: opaciﬁcation of the left cavities; c: homogenous myocardial
pplications
schemic stress
his  is  the  main  indication  for  perfusion  sequences.  The
earch  for  ischemia  by  MRI  has  given  rise  to  a  great  many
tudies  that  place  it  at  least  at  the  diagnostic  level  of
ated  SPECT  imaging.  The  main  advantage  of  the  MRI  is  the
bsence  of  exposure  to  ionizing  radiation  [3].  The  main  limit
n  this  context  is  the  difﬁculty  of  including  stress.
Radiologists  are  familiar  with  the  other  limits  or  con-
raindications  for  MRI:  obesity  and  claustrophobia  (the  latter
ften  induced  by  the  former),  non-magneto  compatible
mplant,  in  particular  a  pacemaker  or  implantable  deﬁbril-
ator,  intra-orbit  foreign  metal  body,  ferromagnetic  vascular
lips,  kidney  failure  or  allergic  antecedents  contraindicating
he  injection  of  gadolinium  chelate.
Among  the  many  studies  backing  up  the  use  of  the  MRI  in
he  detection  of  coronary  disease,  two  of  them  have  to  be
entioned.
Watkins  et  al.  [4]  carried  out  a monocentric  trial  toompare  MRI  under  adenosine  with  Fractional  Flow  Reserve
FFR),  a  robust  hemodynamic  reference  to  determine  the
igniﬁcance  of  arterial  stenosis.  By  way  of  a  reminder,  FFR
s  the  invasive  measurement  (during  a  coronary  angiography)
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subendocardial  perfusion  at  the  hypertrophic  zones.  This
anomaly  is  correlated  with  functional  angina  pectoris,  which
may  be  observed  in  this  context  (Fig.  5).
Figure 3. Cardiac slice in the vertical long axis plane. Late340  
f  a  mean  pressure  gradient  between  the  thoracic  aorta
nd  an  endocoronary  point  located  downstream  from  the
tenosis  studied.  A  stenosis  is  considered  to  be  signiﬁcant  if
he  difference  in  mean  pressure  between  these  two  points
xceeds  25%.  The  FFR  is  considered  to  be  normal  when  it
xceeds  75%,  abnormal  when  below.
The  results  of  this  study  support  the  use  of  MRI.  In  fact,
he  evaluation  by  patients  provides  the  following  results:
f  the  76  patients  who  had  a  lesion  that  was  judged  posi-
ive  by  MRI,  74  had  at  least  one  vessel  with  a  FFR  less  than
5%  (2  false  positives).  Of  the  25  patients  where  the  MRI  did
ot  detect  an  anomaly,  four  had  a  pathological  FFR  (false
egatives).  The  sensitivity  per  patient  was  95%,  the  speci-
city  91%,  the  positive  predictive  value  97%,  the  negative
redictive  value  84%.  The  study  by  segment  provided  simi-
ar  results  with  a  sensitivity  of  91%,  a  speciﬁcity  of  94%,  a
ositive  predictive  value  of  91%  and  a  negative  predictive
alue  of  94%.
In  the  English,  bi-centric  CE-MARC  (Clinical  Evaluation
f  MAgnetic  Resonance  in  Coronary  heart  disease)  study,
ecently  published  in  The  Lancet,  Greenwood  et  al.  [5]  com-
ared  MRI  including  perfusion  under  stress  by  adenosine
ith  gated  SPECT  (tetrofosmine  labeled  with 99mtechnetium)
n  angina  patients  with  at  least  one  cardiovascular  dis-
ase  risk  factor.  The  coronagraphy  was  the  reference.  The
RI  protocol  chosen  was  very  complete  (as  opposed  to  a
ast  ‘‘MR  Impact’’  study  that  only  took  into  account  the
erfusion  analysis),  associating  a  CINE  analysis,  coronary
R-angiography,  and  late  enhancement  with  rest-stress  per-
usion  sequences.
The  positivity  criterion  for  the  MRI  was  composite:
n  anomaly  in  the  segment  kinetics  or  a  ﬁrst  pass  per-
usion  anomaly  under  vasodilator  stress,  or  coronary  stenosis
evealed  by  MR-angiography,  or  typical  subendocardial  late
nhancement  typical  of  necrosis,  resulting  in  the  examina-
ion  being  considered  positive.
The  results  of  the  CE-MARC  study  support  the  use  of  MRI.
he  reference  method  and  technique  have  even  disadvan-
aged  MRI.  In  fact,  in  the  patients  with  a  normal  coronary
ngiography  and  scintigraphy  and  a  (non-transmural)  suben-
ocardial  sequela  of  infarction  by  MRI,  the  authors  consider
he  result  as  a  false  positive  of  MRI  in  spite  of  the  obvious
oronary  disease.  The  sensitivity  (86.5%)  and  the  nega-
ive  predictive  value  (90.5%)  of  MRI  was  signiﬁcantly  higher
P  <  0.0001)  than  that  of  the  scintigraphy  (66.5%  and  79.1%
espectively).  However,  the  speciﬁcity  and  positive  pre-
ictive  value  of  the  tests  did  not  present  a  signiﬁcant
ifference.
MRI  is  currently  little  used  in  France  in  the  diagnosis  of
oronary  disease  and  myocardial  ischemia.  The  main  reasons
or  this  underuse  are  the  mediocre  position  of  our  country
n  terms  of  the  number  of  machines  but,  even  more  so,  the
arsimonious  use  of  French  MRI  machines  in  the  exploration
f  the  heart.  Finally,  too  few  radiologists  or  cardiologists
re  invested  in  this  ﬁeld.  The  remuneration  of  stress  MRI
hen  compared  with  that  of  nuclear  medicine  procedures
ay  also  be  mentioned.ost-infarction
RI  is  an  examination  that  is  increasingly  requested  after
yocardial  infarction  (often  towards  D2  for  practical
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easons, at  the  risk  of  mildly  overestimating  the  volume
f  necrosis),  whether  revascularization  was  or  was  not
arried  out  [6].  The  main  purpose  of  this  examination  is
o  assess  the  residual  viability  of  the  myocardium.  CINE
equences  (whether  or  not  associated  with  a  stress  inotropic
gent  by  dobutamine)  and  late  enhancement  allow  for  an
ptimum  study  of  the  myocardial  viability  (segmental  and
ransmural  extension)  and  guide  the  care.  In  this  context,
he  semiology  provided  by  ﬁrst  pass  perfusion  sequences
s  important.  In  fact,  these  sequences  provide  informa-
ion  about  the  microvascularization  of  the  myocardium  that
s  not  analyzable  by  coronagraphy  (or  coronary  CT-scan),
xaminations  limited  to  the  study  of  the  epicardial  arterial
runks.
Delayed  subendocardial  perfusion  may  be  observed  that
oes  not  persist  at  the  late  time.  In  this  case,  we  speak  of
‘slow  ﬂow’’.
At  a  more  severe  stage,  this  perfusion  anomaly  that
s  visible  in  ﬁrst  pass  perfusion  persists  and  remains  dis-
inctly  visible  in  the  late  enhancement  sequences.  This
attern  deﬁnes  ‘‘no-reﬂow’’  when  there  has  been  revas-
ularization,  or  microvascular  damage  in  the  contrary  case
infarction  seen  late).  The  impaired  segments  are  not
iable  and  this  situation  announces  ventricular  remodeling
Fig.  3).
The  no-reﬂow  is  a  major  prognostic  element  whose
earch  may  justify  the  systematic  use  of  MRI  in  post-
nfarction  [7]. The  perfusion  sequence  may  also  identify
n  intracavity  thrombus  that  is  difﬁcult  to  diagnose  by
onography,  requiring  anticoagulation  (Fig.  4).  The  ﬁrst  pass
iagnosis  is  conﬁrmed  at  the  late  times,  in  particular  in  the
hase-sensitive  inversion  recovery  sequences.
on-ischemic myocardiopathy
ypertrophic  cardiomyopathy
he  ﬁrst  pass  perfusion  sequence  may  reveal  a delay  innhancement sequence revealing extensive anterior infarction with
 no-reﬂow phenomenon. The perfusion anomaly was visible as
f the ﬁrst pass and remains visible at late time, attesting to a
icrovascularization anomaly and a poor prognosis.
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Figure 4. Demonstration as of the ﬁrst pass perfusion sequence
(4-chamber view) of a small thrombus lining the bottom of inferior
lateral infarction. This diagnosis will be conﬁrmed by sequences
Figure 6. Image extracted from a ﬁrst pass perfusion sequence
in a young patient suffering from acute myopericarditis (healthy
coronaries). Note the lateral and, to a lesser degree, anterior hyper-
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twith late enhancement, in particular the PSIR sequence.
MRI  is  often  requested  after  the  detection  of  hypertrophy
by  cardiac  sonography  to  eliminate  amyloidosis  [8,9]. In  this
case,  we  observe  modiﬁcations  in  the  ﬁrst  pass  enhancement
kinetics  of  the  myocardium,  shortening  of  the  inversion  time
TI  and  late  diffuse  enhancement  affecting  both  the  ventricle
walls  and  the  atrial  or  septal  walls.
Myopericarditis
MRI  is  currently  the  reference  technique  for  the  diagnosis  of
myopericarditis  [10].  The  ﬁrst  pass  and  late  enhancement
sequences  are  necessary  for  the  diagnosis.  The  perfusion
sequence  may  reveal  enhancement  of  the  layers  of  the
pericardium  and  subepicardial  hyperhemia  (Fig.  6).  This
epicardial  hypersignal  of  inﬂammatory  origin,  most  often
apico-lateral,  may  give  rise  to  errors  in  interpretation.
In  fact,  the  normal  signal  of  the  subendocardial  topogra-
phy  may  be  erroneously  considered  to  be  a  hyposignal  of
ischemic  origin.  In  this  context  of  thoracic  pain  with  electric
anomalies  and  increase  in  troponine,  imaging  of  the  coro-
naries  is  most  often  carried  out  (coronagraphy  or  coronary
CT-scan).  The  absence  of  coronary  artery  disease  and  linear
C
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Figure 5. Severe hypertrophic cardiomyopathy. Imaging in the short ax
thickness of the myocardium in diastole; b: slice extracted from a perfu
is habitual in this disease.emia on the epicardial side that may be mistaken for an image of
ubendocardial ischemia.
r  nodular,  subepicardial  late  enhancement  helps  conﬁrm
he  diagnosis  of  myopericarditis  and  set  up  adapted  surveil-
ance.
ngeitis
ardiac  impairment  is  possible  within  a  context  of  anti-
eutrophil  cytoplasmic  autoantibody  (ANCA)  vascularitis,
uch  as  Churg-Strauss  disease  [11]  or  Wegener’s  granulo-
atosis  [12].  Suspicion  of  cardiac  impairment  in  this  context
hould  lead  to  an  exploration  by  MRI.  The  analysis  of  the
rst  pass  perfusion  may  be  pathological,  revealing  focal  per-
usion  anomalies  without  vascular  systematization.
The  same  type  of  anomaly  may  be  observed  in  thrombotic
hrombocytopenic  purpura  and  MRI  may  be  more  efﬁcient
han  scintigraphy  in  this  context  [13].
ongenital heart diseasenalysis  of  the  ﬁrst  pass  perfusion  directed  toward  a  sus-
ected  anomaly  may  be  of  use  in  this  context.  For  example,
is of the heart. a: balanced FFE sequence revealing the pathological
sion sequence showing the delayed subendocardial perfusion that
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one  or  several  slices  will  be  placed  in  4-chamber  view  to
demonstrate  a  shunt.
Alternatives
3T
In  spite  of  the  theoretical  advantages,  the  3T  ﬁeld  has  still
not  demonstrated  its  superiority  over  the  1.5T  in  the  anal-
ysis  of  myocardial  perfusion  [14].  It  should  be  noted  that,
in  certain  recent  studies,  ﬁrst  pass  perfusion  quantiﬁcation
techniques  have  been  proposed  with  assessment  of  the  input
function  [15].
Arterial Spin Labeling (ASL)
In  the  small  animal,  the  myocardial  perfusion  cannot  be
analyzed  by  the  perfusion  of  gadolinium  due  to  the  high
heart  rate.  However,  the  analysis  of  perfusion  is  of  prime
importance  in  cardiovascular  pharmacology  to  analyze  the
effect  of  new  treatments.  Among  the  strategies  devel-
oped,  measurement  of  the  T1  relaxation  time  by  arterial
spin  labeling  seems  to  be  highly  efﬁcient  [16].  Brieﬂy,  the
principle  is  to  obtain  two  T1  mappings,  one  with  global  satu-
ration,  the  other  with  a  selective  saturation.  The  difference
between  the  two  relaxation  curves  represents  the  myocar-
dial  perfusion  (Fig.  7).  The  ability  to  quantify  the  myocardial
perfusion  is  of  great  value  in  diffuse  myocardial  disease,
such  as  that  observed  with  hypertension  or  diabetes.
In short, can we do without the analysis of
myocardial perfusion?
No,  analysis  of  myocardial  perfusion  is  a  basic  element
in  cardiac  exploration  by  MRI.  It  is  the  key  sequence  of
MRI  under  vasodilator  stress,  in  the  search  for  myocar-
dial  ischemia,  an  examination  that  takes  into  account
recent  knowledge  and  should  develop  considerably.  The  new
Figure 7. Diagram illustrating the principle of arterial spin label-
ing to measure myocardial perfusion in the small animal. Two T1
relaxation curves are obtained, one after global saturation, the
other after selective saturation. The myocardial perfusion is deter-
mined from these two curves.
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echniques  aim  at  the  relative  or  absolute  quantiﬁcation  of
yocardial  perfusion.
TAKE-HOME  MESSAGES
• Any  cardiac  MRI  examination  should  include  rest
perfusion.
• The  analysis  of  perfusion  under  vasodilator  stress  by
MRI  is  an  alternative  to  scintigraphy.
• Rest-stress  perfusion  should  always  be  compared
with  the  clinical  data  and  the  results  of  other
sequences:  in  particular  global  and  segmental
kinetics,  edema,  late  enhancement.
• The  main  indication  for  myocardial  perfusion  MRI
is  the  search  for  arguments  indicating  a  coronary
disease.  If  the  examination  is  positive,  the  planning
of  the  treatment  depends  on  its  results.
linical case
his  74-year-old  man  was  referred  to  cardiology  for  an
ssessment  of  rapidly  progressing  dyspnea,  associated  with  a
istinct  change  in  his  general  condition.  He  has  a past  history
f  stroke  and  renal  infarction.  The  transthoracic  sonography
f  the  heart  reveals  diffuse  hypertrophy  and  an  alteration
n  the  left  ventricular  ejection  fraction.
Cardiac  MRI  is  carried  out  in  cardiac  synchronization
efore  and  after  the  injection  of  contrast  product.  The  LVEF
n  MRI  is  low  at  35%,  and  the  myocardial  mass  has  increased
o  137  g/m2. A  global  alteration  in  the  bi-ventricular  kinetics
s  noted  (Fig.  8).
uestions
.  What  is  your  diagnostic  hypothesis  in  this  clinical  context?
.  What  is  the  best  MRI  sequence  in  this  disease?
.  Describe  the  perfusion  imaging  anomalies  in  this  patient.
o  they  suggest  the  diagnosis  proposed  in  Question  1?
nswers
.  Global  hypokinetic  hypertrophy  in  this  age  group  should
uggest  cardiac  amyloidosis,  a  disorder  in  which  MRI  is  often
ery  efﬁcient.
.  The  key  sequences  are  the  TI  scouting  that  often  reveals
 shortening  of  the  myocardial  inversion  time  and  late
nhancement  that  is  positive,  very  distinct,  without  vas-
ular  systematization,  with  subendocardial  predominance.
his  late  enhancement  is  speciﬁc  in  that  it  not  only  reaches
he  left  ventricular  myocardium  but  also  the  right  ventricle,
he  atria  and  the  interatrial  septum.
.  In  this  context,  the  ﬁrst  pass  perfusion  imaging  is
ften  helpful,  demonstrating,  as  in  this  patient,  a  non-
ystematized  subendocardial  hyposignal  (c).  The  diagnosis
trongly  indicated  by  the  MRI  was  conﬁrmed  by  the
iopsy.
Is  it  possible  to  do  without  the  study  of  myocardial  perfusion  in  2013?  1343
Figure 8. Cardiac MRI before and after the injection of contrast product. a: 4-chamber view at diastole (a1) and systole (a2); b: short
 the 4axis view at diastole (b1) and systole (b2); c: ﬁrst pass perfusion in
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